Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Gemini Space Station $450 million IPO
The shares are listed on the Nasdaq Global Select Market
Alnylam Pharmaceuticals $661.25 million convertible senior notes offering
The 0% convertible notes are due 2028
Legence $728 million IPO
The shares are listed on the Nasdaq Global Select Market
Maze Therapeutics $150 million private placement
The PIPE included common stock and pre-funded warrants
Crane NXT €445 million acquisition of Antares Vision
We are advising Crane NXT on the transaction
Great Elm Capital $50 million notes offering
We advised Great Elm Capital on the offering
Figure Technology Solutions $788 million IPO
The shares are listed on the Nasdaq Global Select Market
Uber Technologies $2.25 billion senior notes offering
The investment-grade notes are due 2031 and 2035
Webster Financial $350 million subordinated notes offering
We advised Webster Financial on the investment-grade offering
JBT Marel $575 million convertible senior notes offering
The 0.375% convertible senior notes are due 2030